Dr. Alberto Martinez-Arizala, MD

Dr. Martinez-Arizala practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Martinez-Arizala's NPI, 1770576068, was assigned on August 23, 2005. Dr. Martinez-Arizala graduated from University of Miami, Miller School of Medicine in 1979. Dr. Martinez-Arizala holds Florida license ME 45547.

Dr. Martinez-Arizala's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Martinez-Arizala's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Martinez-Arizala is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Martinez-Arizala practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Martinez-Arizala's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Martinez-Arizala is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Martinez-Arizala is licensed in Florida.

Dmand AI lists fibromyalgia and chronic pain, lower back pain, mobility impairment and neck pain and spine problems among the conditions Dr. Martinez-Arizala treats.

CMS data shows 209 Medicare services from Dr. Martinez-Arizala across 5 procedure codes in 2024, for 154 Medicare patients. Medicare paid $17,052 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 154 Medicare patients who saw Dr. Martinez-Arizala in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have arthritis, and 73% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Martinez-Arizala's median patient age at 68, with 55% women.

In 2024, Dr. Martinez-Arizala wrote 715 Medicare Part D claims for 147 patients. 99% of them were for generic drugs. CMS names the drug for 600 of them, across 10 drugs with 11 or more claims each, at $14,616 in total drug cost. In 2023, CMS named 594 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Martinez-Arizala for performance year 2024, reported as part of a group. Dr. Martinez-Arizala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Martinez-Arizala as offering telehealth.

Dmand AI links 30 papers to Dr. Martinez-Arizala, published from 2011 to 2023. 2012 was the busiest year, with 2. The most frequent topics are Spinal Cord Injuries, Spinal Cord and Neuralgia. Dr. Martinez-Arizala has published most often in J Pharmacol Exp Ther. Dr. Martinez-Arizala's most frequent co-authors are Jonathan Russell Jagid, MD, Corneliu Luca, MD and Patricia Wilson Nance, MD.

Dmand AI links Dr. Martinez-Arizala to 2 clinical trials. Conditions studied include Autonomic Dysreflexia, Spinal Cord Injuries and Autonomic Nervous System Diseases.

CMS Open Payments shows 19 general payments to Dr. Martinez-Arizala from 7 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 43% of the total. Adare Pharmaceuticals, Inc. paid the most, $4,429.

Dmand AI lists 2 awards for Dr. Martinez-Arizala, most recently CMS Stage 1 EHR in 2013.

Dr. Martinez-Arizala graduated from University of Miami, Miller School of Medicine in 1979. Dr. Martinez-Arizala is a member of AAN and American Spinal Cord Injury Association.

Dr. Martinez-Arizala is in network with 9 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.